Status:

RECRUITING

A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)

Lead Sponsor:

University of Texas at Austin

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Asthma in Children

Eligibility:

All Genders

5-12 years

Phase:

NA

Brief Summary

This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school...

Detailed Description

This is a pilot two-arm, parallel design, randomized, controlled clinical trial that will test a scalable, culturally-tailored, multilayered asthma intervention, Asthma Guardian, designed to reduce as...

Eligibility Criteria

Inclusion Criteria:

  1. Provision of signed and dated informed consent forms.

  2. Who has a child who is 5-12 years of age

  3. Whose child meets criteria for current persistent asthma defined as either:

    1. On a long-term controller medication for asthma, or

    2. Meet NAEPP guideline requirements for persistent disease:)(35)

      • Asthma symptoms 3 or more days per week over the past 2 weeks OR
      • Nocturnal asthma symptoms at least 3 times in the past month
  4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months

  5. Parent/Caregiver identifies as Mexican American or other Hispanic descent

  6. Whose child has clinician diagnosed asthma

  7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access)

  8. Whose child is not currently participating in another asthma study.

The parent/caregiver is the primary study participant, but the child will be asked to complete some surveys at baseline and six months, so an assent will be obtained from the child.

Exclusion Criteria:

  • An individual who meets any of the following criteria will be excluded from participation in this study:

    1. Unwilling to provide consent for research activities
    2. Cognitive inability to provide consent
    3. Whose child has evidence of other chronic lung or significant cardiovascular disease
    4. Whose child has a history of intubation for asthma

Key Trial Info

Start Date :

March 22 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05892302

Start Date

March 22 2024

End Date

May 1 2025

Last Update

July 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas at Austin

Austin, Texas, United States, 78712